This article is more than 5 years old. Information may no longer be current.
Evolving Management of EoE, Continued Peer-Tested Content
Optimism rises to the top after 2 decades of change in eosinophilic esophagitis care — from diagnosis to monitoring to treatment. As practitioners and patients alike await an FDA-approved treatment and less invasive diagnostic and monitoring techniques, they look ahead with hope.
“These teams, working with patients and advocacy groups, have made great strides in increasing our understanding of this disease, and ongoing collaborations hold great promise for the future,” Evan S. Dellon, MD, MPH, from the University of North Carolina, concluded in a recent review.
Speaking with Dellon and other experts, Healio Gastroenterology’s featured article this month delves into how far we have come in looking at EoE and how far we have to go to fulfill the need for effective treatment of patients with EoE.
Additionally, this month, we bring you peer-tested content from a non-GI meeting, the American Society of Clinical Oncology’s annual meeting. At meetings like ASCO, experts in other fields often present the latest and greatest data on gastrointestinal cancers. We hope our inclusion of the most trafficked items from that meeting coverage helps you, our readers, better manage your patients in this widespread continuum of care.
Please visit us at Healio.com/GI for daily news from ongoing meetings like ASCO and breaking news within the industry and regulatory spaces on top of our peer-tested clinical care coverage.
The Editors Healio Gastroenterologygastroenterology@slackinc.com